Safety and Efficacy of INGAP-Peptide in Patients With Type 1 Diabetes
Status:
Completed
Trial end date:
2004-05-01
Target enrollment:
Participant gender:
Summary
Insulin is a chemical that the body needs in order to use or store sugar. It is made by a
type of cell called a beta cell which resides in an organ known as the pancreas. Type 1
diabetes is a disease where the beta cells have been destroyed so that little or no insulin
is made. Sugar levels rise in the blood as a result. INGAP-Peptide is being tested to attempt
to create new beta cells in the pancreas, and to restore the ability to produce insulin in
type 1 diabetic patients.